These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3224706)

  • 41. Enantiomers of C(5)-chiral 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives: Analytical and semipreparative HPLC separation, chiroptical properties, absolute configuration, and inhibitory activity against monoamine oxidase.
    Cirilli R; Ferretti R; Gallinella B; Turchetto L; Bolasco A; Secci D; Chimenti P; Pierini M; Fares V; Befani O; La Torre F
    Chirality; 2004 Nov; 16(9):625-36. PubMed ID: 15382204
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The importance of substrate structure in selective inhibition of mitochondrial monoamine oxidase activity by several inhibitors].
    Severina IS
    Biokhimiia; 1973; 38(3):608-15. PubMed ID: 4798599
    [No Abstract]   [Full Text] [Related]  

  • 43. Monoamine oxidases: versatility of catalytic properties and possible biological functions.
    Gorkin VZ
    Adv Pharmacol Chemother; 1973; 11():1-50. PubMed ID: 4201892
    [No Abstract]   [Full Text] [Related]  

  • 44. Purification and properties of amine oxidases in brain and connective tissue (dental pulp).
    Nagatsu T; Nakano G; Mizutani K; Harada M
    Adv Biochem Psychopharmacol; 1972; 5():25-36. PubMed ID: 5054205
    [No Abstract]   [Full Text] [Related]  

  • 45. [Relationship between the structure of the substrate and the activity of mitochondrial monoamine oxidase].
    Severina IS; Sheremet'evskaia TN
    Biokhimiia; 1969; 34(1):125-35. PubMed ID: 5801313
    [No Abstract]   [Full Text] [Related]  

  • 46. 1-N-substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: synthesis and evaluation as MAO inhibitors.
    Gökhan N; Yeşilada A; Uçar G; Erol K; Bilgin AA
    Arch Pharm (Weinheim); 2003 Aug; 336(8):362-71. PubMed ID: 14502756
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors.
    Matos MJ; Viña D; Picciau C; Orallo F; Santana L; Uriarte E
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5053-5. PubMed ID: 19628387
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hydrazine derivative modification of the activity of brain mitochondrial monoamine oxidases].
    Kalninia IE; Baumanas EA; Kaĭrane ChB; Gorkin VZ
    Vopr Med Khim; 1981; 27(6):773-9. PubMed ID: 7336653
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selective monoamine oxidase inhibitors. II. 4-aminophenylalkylamine derivatives.
    Florvall L; Ask AL; Ross SB; Ogren SO; Holm AC
    Acta Pharm Suec; 1983; 20(4):255-70. PubMed ID: 6605662
    [No Abstract]   [Full Text] [Related]  

  • 50. Inhibitors of monoamine oxidase IV. 6(or 8)-Substituted tetrahydro-beta-carbolines and their 9-methyl analogs.
    Ho BT; McIsaac WM; Tansey LW
    J Pharm Sci; 1969 Aug; 58(8):998-1001. PubMed ID: 5344539
    [No Abstract]   [Full Text] [Related]  

  • 51. [Pharmacologic properties of several derivatives of 2-methyl-3-carboxy-4,5,6,7-tetrahydroindole].
    Shadurskaia SK; Khomenko AI; Nekrashevich AI
    Farmakol Toksikol; 1977; 40(2):177-81. PubMed ID: 852558
    [No Abstract]   [Full Text] [Related]  

  • 52. [On the selective inhibition by alpha-substituted tryptamine derivatives of the enzymatic deamination of serotonin].
    Gorkin VZ; Tat'ianenko LV; Suvorov NN; Nekliudov AD
    Biokhimiia; 1967; 32(5):1036-46. PubMed ID: 5599890
    [No Abstract]   [Full Text] [Related]  

  • 53. 5-(Aminomethyl)-3-aryldihydrofuran-2(3H)-ones, a new class of monoamine oxidase-B inactivators.
    Ding Z; Silverman RB
    J Med Chem; 1992 Mar; 35(5):885-9. PubMed ID: 1548678
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New indolyl peptidyl esters as MAO inhibitors.
    Sharma M; Gujrati VR; Nath C; Bhargava KP; Shanker K
    Pharmacol Res Commun; 1982 Oct; 14(9):827-37. PubMed ID: 7178212
    [No Abstract]   [Full Text] [Related]  

  • 55. Inhibitors of monoamine oxidase. V. Effect of substitution on the transport of tetrahydro-beta-carboline analogs to mouse brain.
    Ho BT; Fritchie GE; Kralik PM; Tansey LW; Walker KE; McIsaac WM
    J Pharm Sci; 1969 Nov; 58(11):1423-5. PubMed ID: 5349767
    [No Abstract]   [Full Text] [Related]  

  • 56. Monoamine oxidase inhibitory potencies and selectivities of 2-[N-(2-propynyl)-aminomethyl]-1-methyl indole derivatives.
    Balsa D; Fernandez-Alverez E; Tipton KF; Unzeta M
    Biochem Soc Trans; 1991 Feb; 19(1):215-8. PubMed ID: 2037154
    [No Abstract]   [Full Text] [Related]  

  • 57. Chemistry and pharmacology of Gentiana lactea.
    Schaufelberger D; Hostettmann K
    Planta Med; 1988 Jun; 54(3):219-21. PubMed ID: 3174858
    [No Abstract]   [Full Text] [Related]  

  • 58. Acetylene compounds of potential pharmacological value. XXXI. Studies on N-(4-tert-amino-2-butynyl) carboxamides as muscarinic agonists.
    Resul B; Ringdahl B; Hacksell U; Svensson U; Dahlbom R
    Acta Pharm Suec; 1979; 16(4):225-32. PubMed ID: 543393
    [No Abstract]   [Full Text] [Related]  

  • 59. [Synthesis of indolinyl-N,N-dimethylcarbamates as reversible anticholinesterase agents].
    Chen BH; Ji QE
    Yao Xue Xue Bao; 1990; 25(4):247-52. PubMed ID: 2281785
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 2-Methyl-3-butyn-2-ol as an acetylene precursor in the Mannich reaction. A new synthesis of suicide inactivators of monoamine oxidase.
    Fowler JS
    J Org Chem; 1977 Jul; 42(15):2637-7. PubMed ID: 874623
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.